{"nctId":"NCT05408429","briefTitle":"Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13","startDateStruct":{"date":"2022-06-24","type":"ACTUAL"},"conditions":["Pneumococcal Disease"],"count":356,"armGroups":[{"label":"2-Dose 20vPnC Group","type":"EXPERIMENTAL","interventionNames":["Biological: 20-valent pneumococcal conjugate vaccine"]},{"label":"1-Dose 20vPnC Group","type":"EXPERIMENTAL","interventionNames":["Biological: 20-valent pneumococcal conjugate vaccine"]},{"label":"13vPnC Group","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: 13-valent pneumococcal conjugate vaccine"]}],"interventions":[{"name":"20-valent pneumococcal conjugate vaccine","otherNames":[]},{"name":"13-valent pneumococcal conjugate vaccine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female toddlers â‰¥12 to \\<24 months of age at the time of consent\n* Healthy toddlers determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study\n* 2 infant doses of Prevenar 13 prior to 12 months of age\n\nExclusion Criteria:\n\n* History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis)\n* Major known congenital malformation or serious chronic disorder\n* Other chronic medical or laboratory abnormality that may increase the risk associated with study participation or, in the investigator's judgment, make the participant inappropriate for the study.\n* Previous vaccination with any investigational pneumococcal vaccine, or planned receipt through study participation","healthyVolunteers":true,"sex":"ALL","minimumAge":"12 Months","maximumAge":"23 Months","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants With Local Reactions Within 7 Days After Last Vaccination","description":"Local reactions included redness, swelling, and pain at the injection site, recorded by parents/legal guardians of participants in an electronic diary (e-diary). Redness and swelling were measured and recorded in measuring device (caliper) units. 1 measuring device unit = 0.5 centimeter (cm). Redness and swelling were graded as mild (greater than \\[\\>\\] 0 to 2.0 cm), moderate (\\>2.0 to 7.0 cm) and severe (\\>7.0 cm). Pain at injection site was graded as mild (hurt if gently touched example, whimpered, winced, protested, or withdrew), moderate (hurt if gently touched, with crying), and severe (caused limitation of limb movement). 95 percent (%) confidence interval (CI) was based on Clopper and Pearson method.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.3","spread":"18.5"},{"groupId":"OG001","value":"29.7","spread":"21.6"},{"groupId":"OG002","value":"32.5","spread":"24.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.2","spread":"7.6"},{"groupId":"OG001","value":"18.6","spread":"12.1"},{"groupId":"OG002","value":"17.9","spread":"11.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.3","spread":"6.9"},{"groupId":"OG001","value":"11.0","spread":"6.0"},{"groupId":"OG002","value":"14.5","spread":"8.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.0"},{"groupId":"OG001","value":"0","spread":"0.0"},{"groupId":"OG002","value":"0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.7","spread":"16.2"},{"groupId":"OG001","value":"21.2","spread":"14.2"},{"groupId":"OG002","value":"25.6","spread":"18.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.0","spread":"8.2"},{"groupId":"OG001","value":"12.7","spread":"7.3"},{"groupId":"OG002","value":"16.2","spread":"10.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","spread":"4.3"},{"groupId":"OG001","value":"8.5","spread":"4.1"},{"groupId":"OG002","value":"9.4","spread":"4.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.0"},{"groupId":"OG001","value":"0","spread":"0.0"},{"groupId":"OG002","value":"0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.8","spread":"21.6"},{"groupId":"OG001","value":"28.8","spread":"20.8"},{"groupId":"OG002","value":"31.6","spread":"23.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.5","spread":"11.1"},{"groupId":"OG001","value":"17.8","spread":"11.4"},{"groupId":"OG002","value":"26.5","spread":"18.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.3","spread":"6.9"},{"groupId":"OG001","value":"11.0","spread":"6.0"},{"groupId":"OG002","value":"5.1","spread":"1.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"0.0"},{"groupId":"OG001","value":"0","spread":"0.0"},{"groupId":"OG002","value":"0","spread":"0.0"}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants With Systemic Events Within 7 Days After Last Vaccination","description":"Systemic events included fever, decreased appetite, drowsiness/increased sleep and irritability, recorded by parents/legal guardians of participants using an e-diary. Fever: temperature \\>=38.0 degree Celsius (C) and categorized as \\>=38.0 to 38.4 degree C,\\>38.4 to 38.9 degree C,\\>38.9 to 40.0 degree C and \\>40.0 degree C. Decreased appetite was graded as mild (decreased interest in eating), moderate (decreased oral intake) and severe (refusal to feed). Drowsiness was graded as mild (increased/prolonged sleeping bouts), moderate (slightly subdued, interfered with daily activity) and severe (disabling, not interested in usual daily activity). Irritability was graded as mild (easily consolable), moderate (required increased attention) and severe (inconsolable, crying could not be comforted). 95% CI was based on Clopper \\& Pearson method.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.6","spread":"4.9"},{"groupId":"OG001","value":"15.3","spread":"9.3"},{"groupId":"OG002","value":"15.4","spread":"9.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":"1.0"},{"groupId":"OG001","value":"6.8","spread":"3.0"},{"groupId":"OG002","value":"10.3","spread":"5.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":"1.4"},{"groupId":"OG001","value":"3.4","spread":"0.9"},{"groupId":"OG002","value":"2.6","spread":"0.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"0.2"},{"groupId":"OG001","value":"5.1","spread":"1.9"},{"groupId":"OG002","value":"2.6","spread":"0.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"0.0"},{"groupId":"OG001","value":"0","spread":"0.0"},{"groupId":"OG002","value":"0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25.4","spread":"17.7"},{"groupId":"OG001","value":"33.1","spread":"24.7"},{"groupId":"OG002","value":"26.5","spread":"18.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.9","spread":"8.9"},{"groupId":"OG001","value":"15.3","spread":"9.3"},{"groupId":"OG002","value":"12.0","spread":"6.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.5","spread":"5.6"},{"groupId":"OG001","value":"14.4","spread":"8.6"},{"groupId":"OG002","value":"13.7","spread":"8.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"0.0"},{"groupId":"OG001","value":"3.4","spread":"0.9"},{"groupId":"OG002","value":"0.9","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.7","spread":"16.2"},{"groupId":"OG001","value":"32.2","spread":"23.9"},{"groupId":"OG002","value":"31.6","spread":"23.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.4","spread":"11.8"},{"groupId":"OG001","value":"25.4","spread":"17.9"},{"groupId":"OG002","value":"21.4","spread":"14.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.3","spread":"2.0"},{"groupId":"OG001","value":"5.9","spread":"2.4"},{"groupId":"OG002","value":"10.3","spread":"5.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"0.0"},{"groupId":"OG001","value":"0.8","spread":"0.0"},{"groupId":"OG002","value":"0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55.3","spread":"45.7"},{"groupId":"OG001","value":"50.8","spread":"41.5"},{"groupId":"OG002","value":"46.2","spread":"36.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.6","spread":"17.0"},{"groupId":"OG001","value":"15.3","spread":"9.3"},{"groupId":"OG002","value":"16.2","spread":"10.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.8","spread":"21.6"},{"groupId":"OG001","value":"32.2","spread":"23.9"},{"groupId":"OG002","value":"29.9","spread":"21.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.0"},{"groupId":"OG001","value":"3.4","spread":"0.9"},{"groupId":"OG002","value":"0","spread":"0.0"}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants With Adverse Events (AEs) From Last Vaccination to 1 Month After Last Vaccination","description":"An AE was any untoward medical occurrence in a participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. 95% CI was based on the Clopper and Pearson method. AEs reported in this endpoint excluded local reactions and systemic events collected from an e-diary.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.4","spread":"15.2"},{"groupId":"OG001","value":"24.6","spread":"17.1"},{"groupId":"OG002","value":"25.6","spread":"18.0"}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants With Serious Adverse Events (SAEs) From Last Vaccination to 1 Month After Last Vaccination","description":"A SAE was any untoward medical occurrence that: resulted in death; required inpatient hospitalization or prolongation of existing hospitalization; resulted in persistent or significant disability/ incapacity; was a congenital anomaly/birth defect; was a suspected transmission via a Pfizer product of an infectious agent, pathogenic or non-pathogenic, was considered serious and other important medical events. 95% CI was based on the Clopper and Pearson method.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.0"},{"groupId":"OG001","value":"0.8","spread":"0.0"},{"groupId":"OG002","value":"0.9","spread":"0.0"}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants With Predefined Serotype-Specific Immunoglobulin G (IgG) Concentrations for the 7 Additional Serotypes 1 Month After Last Vaccination","description":"Pneumococcal serotype-specific IgG concentrations were measured for serum samples for 7 additional serotypes: 8, 10A, 11A, 12F, 15B, 22F, 33F. The predefined level was 0.35 microgram per milliliter (mcg/mL) for all 7 additional serotypes. 95% CI was based on the Clopper and Pearson method.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"98.1","spread":null},{"groupId":"OG002","value":"8.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.0","spread":null},{"groupId":"OG001","value":"87.0","spread":null},{"groupId":"OG002","value":"1.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.0","spread":null},{"groupId":"OG001","value":"96.3","spread":null},{"groupId":"OG002","value":"13.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91.2","spread":null},{"groupId":"OG001","value":"54.6","spread":null},{"groupId":"OG002","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"75.9","spread":null},{"groupId":"OG002","value":"6.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"94.4","spread":null},{"groupId":"OG002","value":"2.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.0","spread":null},{"groupId":"OG001","value":"83.3","spread":null},{"groupId":"OG002","value":"3.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Serotype-specific IgG Geometric Mean Concentrations (GMC) 1 Month After Last Vaccination","description":"Pneumococcal serotype-specific IgG concentrations were measured for serum samples for 13vPnC serotypes: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F and 7 additional serotypes: 8, 10A, 11A, 12F, 15B, 22F, 33F. Assay results below the lower limit of quantitation (LLOQ) were set to 0.5\\*LLOQ. GMC and corresponding 2-sided 95% CIs were calculated by exponentiating mean logarithm of concentration, corresponding 2-sided 95% CIs (based on Student's t distribution).","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.66","spread":null},{"groupId":"OG001","value":"2.40","spread":null},{"groupId":"OG002","value":"3.38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.78","spread":null},{"groupId":"OG001","value":"0.95","spread":null},{"groupId":"OG002","value":"1.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.09","spread":null},{"groupId":"OG001","value":"4.54","spread":null},{"groupId":"OG002","value":"5.67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.61","spread":null},{"groupId":"OG001","value":"2.03","spread":null},{"groupId":"OG002","value":"2.46","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.55","spread":null},{"groupId":"OG001","value":"12.45","spread":null},{"groupId":"OG002","value":"16.28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.17","spread":null},{"groupId":"OG001","value":"4.87","spread":null},{"groupId":"OG002","value":"6.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.78","spread":null},{"groupId":"OG001","value":"4.41","spread":null},{"groupId":"OG002","value":"6.32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.44","spread":null},{"groupId":"OG001","value":"3.94","spread":null},{"groupId":"OG002","value":"5.36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.58","spread":null},{"groupId":"OG001","value":"7.37","spread":null},{"groupId":"OG002","value":"8.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.84","spread":null},{"groupId":"OG001","value":"3.13","spread":null},{"groupId":"OG002","value":"3.78","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.31","spread":null},{"groupId":"OG001","value":"6.36","spread":null},{"groupId":"OG002","value":"6.89","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.25","spread":null},{"groupId":"OG001","value":"8.78","spread":null},{"groupId":"OG002","value":"10.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.06","spread":null},{"groupId":"OG001","value":"4.45","spread":null},{"groupId":"OG002","value":"6.32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.16","spread":null},{"groupId":"OG001","value":"7.56","spread":null},{"groupId":"OG002","value":"0.05","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.54","spread":null},{"groupId":"OG001","value":"1.32","spread":null},{"groupId":"OG002","value":"0.01","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.83","spread":null},{"groupId":"OG001","value":"2.72","spread":null},{"groupId":"OG002","value":"0.03","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.72","spread":null},{"groupId":"OG001","value":"0.33","spread":null},{"groupId":"OG002","value":"0.01","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.21","spread":null},{"groupId":"OG001","value":"0.95","spread":null},{"groupId":"OG002","value":"0.03","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.45","spread":null},{"groupId":"OG001","value":"8.66","spread":null},{"groupId":"OG002","value":"0.01","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.94","spread":null},{"groupId":"OG001","value":"1.68","spread":null},{"groupId":"OG002","value":"0.02","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Predefined IgG Concentrations for the 13 Matched Serotypes 1 Month After Last Vaccination","description":"Pneumococcal serotype-specific IgG concentrations were measured for serum samples for 13vPnC serotypes:1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,19A,19F, 23F. Predefined level was 0.35 mcg/mL for all 13vPnC serotypes except serotypes 5, 6B, and 19A, which had predefined levels of 0.23, 0.10, and 0.12 mcg/mL, respectively. 95% CI was based on the Clopper and Pearson method.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"94.1","spread":null},{"groupId":"OG001","value":"94.4","spread":null},{"groupId":"OG002","value":"98.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88.2","spread":null},{"groupId":"OG001","value":"87.0","spread":null},{"groupId":"OG002","value":"93.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98.0","spread":null},{"groupId":"OG001","value":"99.1","spread":null},{"groupId":"OG002","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97.1","spread":null},{"groupId":"OG001","value":"96.3","spread":null},{"groupId":"OG002","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"99.1","spread":null},{"groupId":"OG002","value":"99.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"98.1","spread":null},{"groupId":"OG002","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"100.0","spread":null},{"groupId":"OG002","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"99.1","spread":null},{"groupId":"OG002","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"99.1","spread":null},{"groupId":"OG002","value":"99.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"98.1","spread":null},{"groupId":"OG002","value":"99.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"100.0","spread":null},{"groupId":"OG002","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null},{"groupId":"OG001","value":"99.1","spread":null},{"groupId":"OG002","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.0","spread":null},{"groupId":"OG001","value":"99.1","spread":null},{"groupId":"OG002","value":"97.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Serotype-Specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After Last Vaccination","description":"OPA titers for the 20 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F, 8, 10A, 11A, 12F, 15B, 22F, and 33F) were determined in randomly selected subsets of participants at 1 month after last vaccination received. OPA titers below the LLOQ were set to 0.5\\*LLOQ. GMTs and 2-sided CIs were calculated by exponentiating the mean logarithm of the titers and the corresponding CIs based on the Student's t distribution.","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46","spread":null},{"groupId":"OG001","value":"79","spread":null},{"groupId":"OG002","value":"105","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"131","spread":null},{"groupId":"OG001","value":"101","spread":null},{"groupId":"OG002","value":"128","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"348","spread":null},{"groupId":"OG001","value":"425","spread":null},{"groupId":"OG002","value":"541","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46","spread":null},{"groupId":"OG001","value":"77","spread":null},{"groupId":"OG002","value":"73","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1470","spread":null},{"groupId":"OG001","value":"1156","spread":null},{"groupId":"OG002","value":"1796","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"698","spread":null},{"groupId":"OG001","value":"452","spread":null},{"groupId":"OG002","value":"790","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1415","spread":null},{"groupId":"OG001","value":"1212","spread":null},{"groupId":"OG002","value":"1367","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1719","spread":null},{"groupId":"OG001","value":"1792","spread":null},{"groupId":"OG002","value":"1930","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"844","spread":null},{"groupId":"OG001","value":"1245","spread":null},{"groupId":"OG002","value":"558","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1861","spread":null},{"groupId":"OG001","value":"1047","spread":null},{"groupId":"OG002","value":"1149","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"512","spread":null},{"groupId":"OG001","value":"731","spread":null},{"groupId":"OG002","value":"973","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"473","spread":null},{"groupId":"OG001","value":"470","spread":null},{"groupId":"OG002","value":"595","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"727","spread":null},{"groupId":"OG001","value":"472","spread":null},{"groupId":"OG002","value":"721","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3446","spread":null},{"groupId":"OG001","value":"1609","spread":null},{"groupId":"OG002","value":"76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6783","spread":null},{"groupId":"OG001","value":"2506","spread":null},{"groupId":"OG002","value":"64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3827","spread":null},{"groupId":"OG001","value":"3416","spread":null},{"groupId":"OG002","value":"235","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17398","spread":null},{"groupId":"OG001","value":"7346","spread":null},{"groupId":"OG002","value":"64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10024","spread":null},{"groupId":"OG001","value":"3898","spread":null},{"groupId":"OG002","value":"58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11820","spread":null},{"groupId":"OG001","value":"6117","spread":null},{"groupId":"OG002","value":"28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43671","spread":null},{"groupId":"OG001","value":"15355","spread":null},{"groupId":"OG002","value":"694","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":121},"commonTop":["Irritability","Injection site erythema (REDNESS)","Hypersomnia (INCREASED SLEEP)","Injection site pain (PAIN)","Decreased appetite (DECREASED APPETITE)"]}}}